Skip to main content
Log in

Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

In 10 patients (8 men and 2 women) aged 28 to 58 years (mean 44.4 years) treated by repeated haemodialysis due to end-stage renal failure, the bleeding time, whole-blood coagulation time, one-stage prothrombin time, thrombin time of plasma, activated partial thromboplastin time (APTT), fibrinogen level and euglobulin lysis time have been determined (1) during a 4-hour haemodialysis using heparin as an antithrombotic agent, and (2) one week later in the course of another haemodialysis using prostacyclin-heparin. The values for any of the above parameters with both anticoagulant treatment types did not differ. Plasma fibrinogen level after haemodialysis was significantly lower after administration of heparin alone as compared with the group treated by prostacyclin-heparin infusion. During haemodialysis performed with prostacyclin-heparin infusion, activation of the blood fibrinolytic system was manifested by a significant shortening of euglobulin lysis time, observed after 1.5 hours and after the end of haemodialysis. The above phenomenon did not occur when haemodialysis was performed with heparin alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barrowclife, T. W., Johnson, E. A., Thomas, D.: Antithrombin III and heparin.Br. Med. Bull., 34, 143 (1978).

    Google Scholar 

  2. Caruana, R. J., Raja, R. M., Bush, J. K., Kramer, M. S., Goldstein, S. J.: Heparin free dialysis: Comparative data results in high risk patients.Kidney Int., 31, 1351 (1987).

    PubMed  CAS  Google Scholar 

  3. Cheney, K., Bonnin, J. A.: Haemorrhage platelet dysfunction and other coagulation defects in uremia.Br. J. Haematol., 8, 215 (1962).

    PubMed  CAS  Google Scholar 

  4. Dembińska-Kieć, A., Kostka-Trabka, E., Gryglewski, R. J.: Effect of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans.Thromb. Haemostas. (Stuttgart),47, 190 (1982).

    Google Scholar 

  5. Di Minno, G., Martinez, J., McKean, M.: Platelet dysfunction in uremia: Multifaceted defect partially corrected by dialysis and normal fibrinogenBlood, 60, 198 (1982).

    Google Scholar 

  6. Glaser, P., Guesde, R., Rouby, J. J., Eurin, B.: Hemodialysis without heparin is possible.Lancet, 1, 579 (1979).

    Article  Google Scholar 

  7. Gryglewski, R. J., Szczeklik, A., Niżankowski, R.: Anti-platelet action of intravenous prostacyclin in man.Thromb. Res., 15, 153 (1978).

    Article  Google Scholar 

  8. Hassanein, A. A., McNicol, G.P., Douglas, A. S.: Relationships between platelet function tests in normal and uraemic subjects.J. Clin. Pathol., 23, 402 (1970).

    PubMed  CAS  Google Scholar 

  9. Horowitz, H. I., Cohen, B. D., Martinez, P., Papayaanou, M. F.: Defective ADP-induced platelet factor-3 activation in uremia.Blood, 30, 331 (1967).

    PubMed  CAS  Google Scholar 

  10. Jubelier, S. J.: Hemostatic abnormalities in renal disease.Am. J. Kidney Dis., 5, 219 (1985).

    Google Scholar 

  11. Lee, R. G., Adamson, C., Kim, S. W.: Competitive adsorption of plasma proteins onto polymer surfaces.Thromb. Res., 4, 485 (1974).

    Article  PubMed  CAS  Google Scholar 

  12. Lindsay, R. M., Prentice, C. R. M., Davidson, J. F., Burton, J. A., McNicol, G. P.: Haemostatic changes during dialysis associated with thrombus formation of dialysis membranes.Br. Med. J., 4, 454 (1972).

    PubMed  CAS  Google Scholar 

  13. Livio, M., Gotti, E., Marchesi, D., Mecca, G., Remuzzi, G., De Gaetano, G.: Uraemic bleeding: Role of anaemia and beneficial effect of red cell transfusions.Lancet, 2, 1013 (1982).

    Article  PubMed  CAS  Google Scholar 

  14. Longmore, D. B., Gueirrara, D., Bennet, S., Smith, M., Bunting, S., Reed, P., Moncada, S., Read, N. G.: Prostacyclin: a solution to some problems of extracorporeal circulation.Lancet, 1, 1002 (1979).

    Article  PubMed  CAS  Google Scholar 

  15. Mannuci, P. M., Remuzzi, G., Pusineri, F., Lombardi, R., Valtecchi, C., Mecca, G., Zimmerman, T. S.: Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.N. Engl. J. Med., 308, 8 (1983).

    Article  Google Scholar 

  16. Marshall, J. W., Ahearn, D. J., Nothum, R. J., Esterly, J., Nolph, K. D., Maher, J. F.: Adherence of blood components to dialyzer membranes — morphological studies.Nephron, 12, 157 (1974).

    Article  PubMed  CAS  Google Scholar 

  17. Meier, H. L., Scott, C. F., Mandle, R., Jr., Webster, M. E., Pierce,R. W., Colman, R. W., Kaplan, A. P.: Requirements for contact activation of human Hageman factorAnn. N. Y. Acad. Sci., 28, 93 (1977).

    Article  Google Scholar 

  18. Nath, N., Lowery, C. T., Niewiarowski, S.: Antigenemic and antiheparin properties of human platelet factor IV (PF IV).Blood, 45, 535 (1975).

    Google Scholar 

  19. O'Grady, J., Warrington, S., Moti, M. J., Bunting, S., Flower, R., Fowle, A. S. E., Higgs, E. A., Moncada, S.: Effects of intravenous infusion of prostacyclin (PGI2) in man.Prostaglandins, 19, 319 (1980).

    Article  PubMed  Google Scholar 

  20. Ostrowski, W.: Wybrane metody z chemii klinicznej. PZWL, Warszawa 1968.

    Google Scholar 

  21. Parzer, S., Panzer, S., Balcke, P., Mannhalter, C.: Identification of proteins adsorbed from human blood hemodialysis membranes during standard hemodialysis. Abstr. XXV. Congr. EDTA, 1988, p. 188.

  22. Rabiner, S. F.: Uremic bleeding.Prog. Hemost. Thromb., 1, 233 (1972).

    PubMed  CAS  Google Scholar 

  23. Rabiner, S. F., Hrodeck, O.: Platelet factor-3 in normal subjects and patients with renal failure.J. Clin. Invest., 47, 901 (1968).

    PubMed  CAS  Google Scholar 

  24. Remuzzi, G., Dodesini, P., Livio, M.: Parathyroid hormone inhibits human platelet function.Lancet, 2, 1321 (1981).

    Article  PubMed  CAS  Google Scholar 

  25. Remuzzi, G., Livio, M., Cavenaghi, A. E., Marchesi, D., Mecca, G., Donati, M. B., Gaetano, G.: Unbalanced prostaglandin synthesis and plasma factors in uremic bleeding. A hypothesis.Thromb. Res., 13, 531 (1978).

    Article  PubMed  CAS  Google Scholar 

  26. Remuzzi, G., Marchesi, D., Cavenaghi, A. E.: Bleeding in renal failure: a possible role of vascular prostacyclin (PGI2).Clin. Nephrol., 12, 127 (1979).

    PubMed  CAS  Google Scholar 

  27. Rosenberg, R. D.: Actions and interactions of antithrombin and heparin.N. Engl.J. Med., 292, 146 (1975).

    Article  PubMed  CAS  Google Scholar 

  28. Rosenberg, R. D.: Heparin action.Circulation, 49, 603 (1974).

    PubMed  CAS  Google Scholar 

  29. Rudowski, W.: Zaburzenia hemostazy w chirurgii. PZWL, Warszawa 1971.

    Google Scholar 

  30. Rylance, P. B., Dodd, N. J., Gordge, M. P., Ireland, H., Lane, D., Weston, M. J.: Prostacyclin (Epoprostenol) allows reduced heparin dosage during haemodialysis. Abstr. XX. Congr. EDTA, 1983, p. 113.

  31. Salzman, W., Rosenberg, R. D., Smith, M. H., Lindon, J. N., Favreau, L.: Effect of heparin and heparin fractions on platelet aggregation.Am. Soc. Clin. Invest., 65, 64 (1980).

    Article  CAS  Google Scholar 

  32. Smith, M., Danviriyasup, K., Crow, J., Cato, A., Park, G., Hassid, A., Dunn, M.: Prostacyclin substitution for heparin in long-term hemodialysis.Am. J. Med., 73, 669 (1982).

    Article  PubMed  CAS  Google Scholar 

  33. Stockenhuber, F., Kyrle, P. A., Sunder-Plabmann, G., Blacke, P., Lechner, K.: Bleeding tendency in chronic renal failure: evidence for an increased generation of prostacyclin in the microvasculature and platelet storage pool defect. Abstr. XXV. Congr. EDTA, 1988, p. 196.

  34. Turney, J. H., Fewell, M. R., Williams, L. C., Parsons, V., Weston, M. J.: Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy.Lancet, 2, 219 (1980).

    Article  PubMed  CAS  Google Scholar 

  35. Turney, J. H., Woods, H. F., Weston, M. J.: The use of prostacyclin in extracorporeal circuits.Hemostasis, Prostaglandins and Renal Disease, 353 (1980).

  36. Von Kaulla, K. N., Schultz, R. L.: Methods for evaluation of human fibrinolysis: Studies with two combined techniques.Am. J. Clin. Pathol. 29, 104 (1958).

    Google Scholar 

  37. Wardle, E. N., Piercy, D. A.: Studies of contact activation of blood in hemodialysis.J. Clin. Pathol., 25, 1045 (1972).

    PubMed  CAS  Google Scholar 

  38. Weston, M. J., Woods, H. F., Ash, G., Bunting, S., Moncada, S., Vane, J. R.: Prostacyclin as an alternative to heparin for hemodialysis in dogs. Prostacyclin. Raven Press, New York 1979, p. 349.

    Google Scholar 

  39. Woods, H. F., Ash, G., Weston, M. J., Bunting, S., Moncada, S., Vane, J. R.: Prostacyclin can replace heparin in haemodialysis in dogs.Lancet, 2, 1075 (1978).

    Article  PubMed  CAS  Google Scholar 

  40. Woods, H. F., Weston, M. J., Bunting, S.: Haemodialysis without heparin.Clin. Nephrol., 12, 122 (1979).

    PubMed  CAS  Google Scholar 

  41. Zucker, M. B.: Biological aspects of heparin action. Heparin and platelet function.Fed. Proc., 36, 47 (1977).

    PubMed  CAS  Google Scholar 

  42. Zusman, R., Rubin, R., Cato, A., Cocchetto, D., Crow, J., Tolkoff-Rubin, N.: hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.N. Engl. J. Med., 304, 934 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuźnifwski, M., Sułowicz, W. & Lisiewicz, J. Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients. International Urology and Nephrology 23, 89–96 (1991). https://doi.org/10.1007/BF02549733

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549733

Keywords

Navigation